SlideShare una empresa de Scribd logo
1 de 61
Descargar para leer sin conexión
Recurrent pregnancy loss
Kamel Mohamed Ibrahim
M.B.B.CH – MSC ain shams University maternity hospital
Specialist in fetomaternal medicine
Member of Egyptian fertility society
Member of Egyptian association of Gynelaparoscopists
INTRODUCTION
• The loss of pregnancy at any stage can be a
devastating
experience
and
particular
sensitivity is required in assessing and
counseling
couples
with
recurrent
miscarriage
• A woman who has suffered a single sporadic
miscarriage has an 80% chance and a
woman with three consecutive miscarriages
a 40-60% chance of her next pregnancy
being successful
recurrent pregnancy loss
This is our hope.
Our Learning Objectives
• Identify possible causes of early pregnancy
loss.
• Outline basic evaluation for recurrent
pregnancy loss (RPL).
• Review current treatment approaches for
these patients.
Definition
• Miscarriage is defined as the spontaneous loss of
pregnancy before the fetus reaches viability.
• A recurrent miscarriage ₌ recurrent pregnancy loss
(RPL) is 3 or more consecutive, spontaneous
pregnancy losses (clinically recognized pregnancies) ,
under 20 week .

Am J Obstet Gynecol 2005;192:240–6
SUB TYPES :
All pregnancy losses, no viable pregnancy
Viable pregnancy followed by pregnancy losses

Pregnancy losses interspersed with viable pregnancie

RPL-TYPES :
•Primary recurrent pregnancy loss" refers to
couples that have never had a live birth,
•“Secondary RPL" refers to those who have had
repetitive losses following a successful pregnancy
Easier to divide into 1st or 2nd trimester losses

• 1st trimester losses :
–
–
–
–
–

PCOS (Polycystic ovary syndrome)
APS (Antiphospholipid syndrome)
Chromosomal abnormalities
Endocrine disorders (untreated DM, thyroid disease)
Uterine abnormalities
• Submucous fibroid
• Subseptate uterus

• 2nd trimester losses :
–
–
–
–

Cervical incompetence
Asherman syndrome (intrauterine synechiae)
Bacterial vaginosis
Uterine abnormalities
• Congenital – bicornuate, septate, subseptate, hypoplasia
• Myomas
– Thrombophilias
Epidemiology
• 50% of all conceptions fail (most unrecognized)
• 13-15% of recognized pregnancies are lost, 90 % of
these before 12-14 weeks
• 10-20% of pregnant women have 1sporadic
spontaneous abortion
• 2% have 2 consecutive Spontaneous Abortion.
• 0.4-1% have 3 consecutive Spontaneous Abortion.
• Spontaneous successful pregnancy after 2miscarriage is 80%

Lee Semin Reprod Med 2000;18(4):433-40
Risk factors

Advanced maternal age :

12-19 year:13%
20 -24 year: 11%Risk factors
25-30 year: 12%
31-35 year: 15%
36-40 year: 25%
>40 year: 50%
BMJ 2000;320:1708–12.

Previous miscarriage :

↑ up to 40% after 3 consecutive pregnancy losses &
prognosis worsens ѐ↑maternal age.
Recurrent Pregnancy Loss 2007
Environmental Risk Factors:
The evidence on the effect of environmental risk factors
is based mainly on data studying women with sporadic rather
than recurrent miscarriage.
Confirmed association
Ionizing irradiation
Organic solvents
Alcohol
Mercury
Lead

Suspected association
 Caffeine (> 300 mg/day)
 Cigarette smoking
(However, current evidence is insufficient to confirm this
association)


(Gardella & Hill Semin Reprod Med 2000;18(4):407-424)

Acta Obstet Gynecol Scand 2003;82:182–8.

Working with or using video display terminals does not increase the
risk of miscarriage.
(J Am Med Womens Assoc 2000;55:84–8, 105.)

The evidence on the effect of anaesthetic gases for theatre workers is
conflicting.
(Mayo Clin Proc 2000;75:273–7).
obesity increases the risk of both sporadic and recurrent miscarriage.
(Fertil Steril 2010;94:290–5).
AETIOLOGY
Only in 50 %, the cause can be determined
(Explained )
Lee Semin Reprod Med 2000;18(4):433-40
1. Genetic (embryonic and parental )

2. Immunologic (autoimmune/alloimmune )
3. Anatomical Factors (Uterine )
4. Infectious causes .
5. Environmental
6. Endocrine
7. Hematologic disorders
Genetic
• Advanced Maternal age α errors in meiosis .
• Oocytes ovulated earlier in life less prone to non
dysjunction
• Repetitive first trimester losses
• Anembryonic pregnancies
• History of malformations or mental retardation.
Genetic
• Embryonic chromosomal abnormalities :
account for 30–57% of further miscarriages.
(Hum Reprod 2002;17:446–51)

– gametogenic error (^ with maternal age) .
– Recurrent aneuploidy
– Euploid abortion

• Parental chromosomal abnormality 3-5% :
The risk of miscarriage is influenced by the size and the
genetic content of the rearranged chromosomal segments.
– most commonly a balanced reciprocal or Robertsonian
translocation.
(BMJ 2006; 332:1012.)
– Inversion
– X chromosome mosaicsm
Immune factors
Autoimmune : (directed to self)
Systemic Lupus Erythmatosus
Antiphospholipid Syndrome

Alloimmune :(directed to foreign tissues/cells)
An abnormal maternal immune response to fetal
or placental antigen.
Systemic Lupus Erythmatosus (SLE) :
-Risk for loss is 20%,mostly in 2nd and 3rd
trimester of pregnancy and associated with
antiphospholipid antibodies.

Antiphospholipid syndrome (APA) :
5 - 15 % of women with RPL may have APA .
inhibition of trophoblastic function and differentiation.
Am J Obstet Gynecol 2005;192:23–30.

activation of complement pathways at the maternal-fetal interface
resulting in a local inflammatory response .( Lupus 2003;12:535–8.)

in later pregnancy, thrombosis of the uteroplacental vasculature .
(Am J Obstet Gynecol 1993;169:1403–6)
Antiphospholipid syndrome
An Autoimmune disorder having specific clinical & lab
criteria:
Clinical features:
•Vascular thrombosis or
•Loss of fetus at or after 10 weeks or
•Preterm delivery at or before 34 weeks or
•3 or more consecutive SAB before 10 weeks

Laboratory features :
•Anti-cardiolipin (aCL) antibodies: IgG or IgM at moderate or
high levels on 2 or more occasions at least 12 weeks apart
•Lupus anticoagulant (LA) antibodies: detected on 2 or more
occasions at least 12 weeks apart
Diagnosed by Revised Sapporo classification (2006):
At least one clinical criteria and one laboratory criteria
Clinical

Laboratory

Thrombosis

≥1 documented episodes of:
Arterial
Venous and/or
Small vessel thrombosis

ACA

ACA of IgG and/or IgM isotype in
medium/high titre (> 40 IU) or
>99th percentile

Pregnancy
morbidity

≥1 unexplained fetal deaths of ≥ 10
weeks POA

LA

Detected

(morphologically normal fetus)

≥1 premature births of ≤ 34th week POA
d/t:
Severe PE or
Placental insufficiency (IUGR)

Anti>99th percentile
beta2glycopro
tein

(morphologically normal neonate)

≥3 unexplained consecutive spontaneous
abortions < 10 week POA

* On 2 or more occasions
At least 12 weeks apart
Alloimmune :
Immune response to non-self components of pregnancy
•Cytotoxic antibodies
•Absence of maternal blocking antibodies
•Inappropriate sharing of HLA
•Disturbances in natural killer cell function and distribution.
Porter Semin Reprod Med 2000;18(4):393-400

Natural killer cells:
There is no clear evidence that altered peripheral blood
NK cells are related to recurrent miscarriage.
T helper (Th1) immunodystrophism

Hum Reprod 2005;20:1123–6.

A meta-analysisconcluded that the available data are not consistent with associations between
cytokine polymorphisms and recurrent miscarriage. (Evidence level

2++)
Anatomical Factors (Uterine )
Uterine anomalies : prevalence of uterine anomalies in recurrent

miscarriage populations ranges between 1.8% and 37.6%

Hum Reprod 2003;18:162–6.

• Uterine septum (the anomaly most commonly associated with pregnancy
loss)
• Hemiuterus (unicornuate uterus)
• Bicornuate uterus
• Didelphic uteri

Diethylstilbestrol-linked condition
Acquired defects (eg, Asherman syndrome)
Incompetent cervix
Leiomyomas
Uterine polyps
Defective endometrial receptivity
the role of uterine anomalies in recurrent miscarriage will remain debatable.
untreated uterine anomalies let women experience high rates of miscarriage
and preterm delivery, with a term delivery rate of only 50%.
Hum Reprod Update 2001;7:161–74.
Fertil Steril 1988; 49:944.
SEPTATE UTERUS
• a septate uterus Where as a partial
septum increases the risk to 60%-75%; a
total septum carries a risk for loss of up to
90%.
• Most common.
• poorest reproductive outcome.
• Fetal survival with untreated cases 6 to 28
%
• The mechanism
– Not clearly understood
– Poor blood supply
»»» poor
Bicornuate Uterus
• 10% of anomalies
• Incomplete fusion of Uterine horns at level of
fundus
• Two separate but communicating endometrial
cavities
• Abortion rate 30%
• Preterm labour 20%
• Metroplasty .
Unicornuate Uterus
• 20% of anomalies
• Agenesis or hypoplasia of one Mullerian duct
• May be alone or accompanied by Rudimentary horn
With presence / absence of cavity Communicating /
Non communicating
• Associated Renal anomalies occur in
40% patients Ipsilateral to hypoplastic horn
Uterus Didelphys
• Least common anomaly -5-7%
• associated with a miscarriage rate of 20.9% and a
preterm delivery rate of 24.4%
Hum Reprod 2003; 18:162–6.
Cervical incompetence
• Diagnosis is clinical, usually based on history
– Miscarriage
•
•
•
•

2nd-trimester miscarriage
Subsequent miscarriages are usually earlier
Preceded by spontaneous rupture of membranes
Bulging membranes through the cervix prior to onset of
labour
• Painless and progressive cervical dilatation
• Fetus alive during miscarriage

– History of cervical surgery (cone biopsy, LLETZ)
LEIOMYOMA
Unclear relationship between uterine leiomyomata
and RPL
• Submucous
• The mechanism – Their position
– Poor endometrial receptivity
– Degeneration with increasing
cytokine production
OTHER UTERINE CAUSES
• Endometrial polyps
• Intrauterine adhesions
– Curettage for pregnancy complications .
– Traumatize basalis layer  granulation
tissue
– Insufficient endometrium to support
fetoplacental growth
– Menstrual irregularities (hypomenorrhea,
amenorrhea), cyclic pelvic pain, infertility.
Endocrine factors
•

•
•
•
•

Poorly controlled diabetes :
– (↑Blood glucose & HbA1c levels in 1st trimester)
↑
risk for loss.
– Miscarriage risk rises with the level of HbA1c
– Well-controlled
No ↑ risk
thyroid disease .
Anti-thyroid antibodies have been linked to recurrent miscarriage.
Hyperprolactinemia
Polycystic ovary syndrome (PCOS)
Presence of at least 2 of the following 3 criteria:
–

Polycystic ovaries
•
•

–
–

≥ 12 follicles in each ovary (<10 mm (2-9 mm in diameter)) and/or
Ovarian volume > 10 cm3

Oligomenorrhea and/or anovulation
Clinical and/or biochemical hyperandrogenism
• The increased risk of miscarriage in women
with PCOS has been recently attributed to
insulin resistance,hyperinsulinaemia and
hyperandrogenaemia. (Hum Reprod 2000;15:612–5.)
• An elevated free androgen index appears to
be a prognostic factor for a subsequent
miscarriage in women with recurrent
miscarriage. (Hum Reprod 2008;23:797–802).
Infective agents
• No infectious agent has been proven to cause
recurrent pregnancy loss
• Certain infections have been associated with
spontaneous loss
– Toxoplasma Gondi, rubella, HSV, CMV, measles, coxsackie
Lee Semin Reprod Med 2000;18(4):433-40

• Routine TORCH screening should be abandoned.
RCOG, 2011.
Bacterial vaginosis
• Presence of BV in the first trimester
– Reported as a risk factor for 2nd-trimester miscarriage or
preterm delivery.
Best Pract Res Clin Obstet Gynaecol 2007;21:375–90.

• A RCT reported that treatment of BV early in the 2ndtrimester with oral clindamycin significantly reduces the
incidence of second-trimester miscarriage and preterm
birth in the general population.
Lancet 2003;361:983–8.

• No data to assess the role of antibiotic therapy in women
with a previous second-trimester miscarriage.
Hematologic disorders
Women with heritable or acquired thrombophilic
disorders have significantly increased risks of pregnancy
loss .
Kutteh Semin Reprod Med 2006;24(1):54-65

Inherited thrombophilic defects :
•
•
•
•

Activated protein C resistance (most commonly due to factor V
Leiden gene mutation).
deficiencies of protein C/S and antithrombin III
hyperhomocysteinaemia
prothrombin gene mutation

are established causes of systemic thrombosis
Carriers of factor V Leiden or prothrombin gene
mutation have double the risk of experiencing
recurrent miscarriage compared with women
without these thrombophilic mutations.
Arch Intern Med 2004;164:558–63.
MISCELLANEOUS
• Environmental chemicals
– Anesthetic gases
• Sporadic spontaneous loss
• No evidence of associations with RPL

• Personal habits
– Obesity »» ↑ Risk of Sporadic spontaneous loss and
RPL
– Smoking associated with ↑ Risk of spontaneous loss
– Alcohol »» ↑ Risk of Sporadic spontaneous loss.

– Caffeine associated with ↑ Risk of spontaneous loss

• Exercise
– does not ↑ sporadic or RPL
Male factor :
•Advanced paternal age may be a risk factor for
miscarriage (at more advanced age than
females)
•Paternal HLA sharing not risk factor for RPL.
•Aside from cytogenetic abnormalities, male
factor contribution to RPL unknown
Hill ASRM 2002 Course 6 p.56
Idiopathic (Unexplained)
• More than 50% of couples with RPL have no
explanation despite extensive evaluation(s)
• Informative and sympathetic counseling appears to
play an important role
Lee Semin Reprod Med 2000;18(4):433-40
How to approach RPL?
Detailed history :
personal history : Age-<16y, >35
MH:oligomenorrhoea, PCO
Present history:
Pattern of losses and if a live embryo or fetus was present
Exposure to environmental,toxins or drugs
Known gynecological or obstetrical infections
Features associated with APS
OBH : GA<^6 w, 6-8w,
FHR+/Past Surgical & Medical history: renal, look for autoimmune disease
(SLE) , D&C , Previous diagnostic tests and treatments
Family history : thrombophilia, birth defects, Consanguinity,RPL
Examination :
– General physical exam
Wt, HT,BMI
Features of PCOS
Features of SLE
Features of thyroid diseases
– Pelvic exam
Speculum
–Any features of genital tract infection,
anomalies, fibroids
How and when to investigate?
Ideally after 3 losses but American Society of
reproductive medicine (ASRM 2008) Define as 2 consecutive
miscarriage
Earlier investigation/referral should be considered for special
cases:
Advanced maternal age (? How old)
Bad obstetric history (e.g. ectopic, IUD)
Medical disorders
History of infertility, known family history.
Patient request due to social reasons

How to Investigate ?
Investigate commoner and treatable causes first
Do not order a blind screen
• Antiphospholipid antibodies : ( Grade D)
– Anticardiolipin antibodies (ACA) & Lupus anticoagulant
2 +ve tests (12 weeks apart )

• Karyotyping : (Grade D )
– Should be performed on products of conception (POC)of the
3rd and subsequent consecutive miscarriages
– Parenteral karyotyping of both partners should be performed
when testing of POC reports an unbalanced structural
chormosomal abnormality.

• Pelvic ultrasound – assess uterine anatomy : (√ )
– HSG can also be used as an initial screening test
– Suspected uterine anomalies may require further
investigations to confirm diagnosis:
• Hysteroscopy
• Laparoscopy
• 3D ultrasound
• 2D ultrasound scanning and/or HSG can be used as an
initial screening test. Combined hysteroscopy and
laparoscopy and possibly 3D ultrasound scanning should be
used for definitive diagnosis. (3)
Hum Reprod Update 2008;14:415–29.

Thrombophilias :
Women with second-trimester miscarriage should be
screened for inherited thrombophilias including factor V
Leiden, factor II (prothrombin) genemutation and protein S.
( 2++)

Lancet 2003;361:901–8.

away from the acute event
when anticoagulation is discontinued
when the woman is not pregnant or on the combined
contraceptive pill.
Endocrine factors
• PCOS screen
– Serum testosterone
– SHBG
• Screening for diabetes, thyroid disorders is only
indicated if there is clinical suspicion. Not recommended
as a routine test.

Infective agents
Not useful
• TORCHES»»
Recurrent Pregnancy Loss Causes, Controversies and Treatment 2007
How to manage ?
Management


Emotional aspect









Lost of pregnancy – can be a devastating
traumatic experience
Can lead to anxiety, stress & depression
Instead of getting sympathy and support,
often made to feel that it is somehow her fault
Under intense pressure to provide a child for
the family
May even lead to family problem @ divorce

Sensitivity is required in assessing and
counselling couples




Approach with sympathy and understanding
DO NOT blame, scold or make her feel at
fault
Treatment - APS
• Pregnant women with APS should be treated with
low-dose aspirin plus heparin to prevent further
miscarriage. (B)
(RCOG 2011)
• Aspirin 81 mg po/day .
• Subcutaneous unfractionated heparin 5000 - 10000
units/12 hours .
• Alternative: LMWH(e.g., enoxaparin 1mg/kg/day)
every 12 hours
potential advantages:
less heparin-induced thrombocytopenia .
administered once daily .
lower risk of heparin-induced osteoporosis. (RCOG 2011)
Neither corticosteroids nor intravenous immunoglobulin
therapy improve the live birth rate of women with recurrent
miscarriage associated with APS. (A)
(RCOG 2011)
Management: Genetic Losses

Abnormal parental karyotype should be referred to
a geneticist. (D)
Genetic counselling »» Reproductive options »»» a further
natural pregnancy with or without a prenatal diagnosis
test, gamete donation and adoption.

Preimplantation Genetic Diagnosis (PGD) : proposed
as a treatment option for translocation carriers
Hum Fertil (Camb) 2001;4:168–71.
Uterine Abnormalities
Treatment

Uterine septum: Hysteroscopy septal resection and
temporary intrauterine device.
Intrauterine adhesions : hysteroscopic division and
temporary intrauterine device: postoperative course of
cyclic estrogen and progesterone therapy.
Fibroids: myomectomy
In women with a singleton pregnancy and a history of one
second-trimester miscarriage attributable to cervical
factors, an ultrasound-indicated cerclage should be
offered if a cervical length of 25mm or less is detected by
transvaginal scan before 24 weeks . (B) RCOG 2011
Management : Endocrine factors
There is insufficient evidence to evaluate the effect of
progesterone supplementation in pregnancy to
prevent a miscarriage (RCOG 2011)
However newer evidences is coming up as large
multicentre study PROMISE is currently on the
way.

(PROMISE,http://www.medscinet.net/promise)
There is insufficient evidence to evaluate the effect of
human chorionic gonadotrophin supplementation in
pregnancy to prevent a miscarriage in women with
recurrent miscarriage. (B)

Suppression of high luteinising hormone levels among
ovulatory women with recurrent miscarriage and
polycystic ovaries does not improve the live birth rate. (A)
(RCOG 2011)
PCOS
• Role of Metformin
– Previously prescribed to reduce risk of recurrent
miscarriage
– Insufficient evidence to evaluate the effect of
metformin supplementation
– Recent meta-analysis of 17 RCTs - metformin has
no effect on sporadic miscarriage risk
– Uncontrolled small studies (no RCTs) – associated
with reduction in miscarriage rate in women with
recurrent miscarriage
Immunotherapy
Paternal cell immunisation
third-party donor leucocytes
trophoblast membranes and intravenous
immunoglobulin (IVIG)
»»»»previous unexplained recurrent miscarriage does
not improve the live birth rate . (A)
Treatment Inherited thrombophilias
For heritable or acquired thrombophilia: heparin
anticoagulation

For elevated homocysteinemia without thrombosis
history (Supplementation with Vitamin B6, B12 and
folic acid)
(Heparin anticoagulation for history of thrombosis)
Heparin therapy during pregnancy may improve the live
birth rate of women with second-trimester miscarriage
associated with inherited thrombophilias. (A)
Management – Unexplained RM
• Women with unexplained recurrent miscarriage have an
excellent prognosis for future pregnancy outcome without
pharmacological intervention if offered supportive care
alone in the setting of a dedicated early pregnancy
assessment unit. (B)
• 75% chance of a eventual live birth in subsequent
pregnancy However, prognosis worsens with:
• Increasing maternal age
• Number of previous miscarriages

the use of empirical treatment in unexplained recurrent
miscarriage is unnecessary and should be resisted
RCOG 2011
Unexplained recurrent miscarriage
Preimplantation genetic screening with in vitro
fertilisation treatment in women with unexplained
recurrent miscarriage does not improve live birth rates.
(C)
Two recent randomised controlled trials reported that
neither of (Aspirin alone or in combination with heparin)
improves the live birth rate among women with
unexplained recurrent miscarriage.
(N Engl J Med 2010;362:1586–96.)

(Blood 2010;115:4162–7.)
immunological
• Paternal cell immunisation, third-party donor
leucocytes, trophoblast membranes
• and intravenous immunoglobulin in women
with previous unexplained recurrent
• miscarriage does not improve the live birth
rate
Thank You

Más contenido relacionado

La actualidad más candente

Epidemiology of Recurrent Pregnancy Loss
Epidemiology of Recurrent Pregnancy LossEpidemiology of Recurrent Pregnancy Loss
Epidemiology of Recurrent Pregnancy LossKirtan Vyas
 
Tocolysis for preterm labour: RCOG Guidelines
Tocolysis for preterm labour: RCOG GuidelinesTocolysis for preterm labour: RCOG Guidelines
Tocolysis for preterm labour: RCOG GuidelinesAboubakr Elnashar
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Recurrent preg loss
Recurrent preg lossRecurrent preg loss
Recurrent preg lossOsama Warda
 
Recurrent Pregnancy Loss
Recurrent Pregnancy Loss Recurrent Pregnancy Loss
Recurrent Pregnancy Loss Raktim123
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilBharati Dhorepatil
 
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
 
Uterine factor in female infertility
Uterine factor in female infertilityUterine factor in female infertility
Uterine factor in female infertilitySantosh Jena
 
Adenomyosis associated infertility
Adenomyosis associated infertilityAdenomyosis associated infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015Aboubakr Elnashar
 
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)    Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years) Lifecare Centre
 
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRole of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRajesh Gajbhiye
 
Management of poor responders
Management of poor respondersManagement of poor responders
Management of poor respondersSandro Esteves
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiBharati Dhorepatil
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1drmcbansal
 

La actualidad más candente (20)

Epidemiology of Recurrent Pregnancy Loss
Epidemiology of Recurrent Pregnancy LossEpidemiology of Recurrent Pregnancy Loss
Epidemiology of Recurrent Pregnancy Loss
 
Tocolysis for preterm labour: RCOG Guidelines
Tocolysis for preterm labour: RCOG GuidelinesTocolysis for preterm labour: RCOG Guidelines
Tocolysis for preterm labour: RCOG Guidelines
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
 
Infertility management 2019
Infertility management 2019Infertility management 2019
Infertility management 2019
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Recurrent preg loss
Recurrent preg lossRecurrent preg loss
Recurrent preg loss
 
Recurrent Pregnancy Loss
Recurrent Pregnancy Loss Recurrent Pregnancy Loss
Recurrent Pregnancy Loss
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
 
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
 
Uterine factor in female infertility
Uterine factor in female infertilityUterine factor in female infertility
Uterine factor in female infertility
 
Adenomyosis associated infertility
Adenomyosis associated infertilityAdenomyosis associated infertility
Adenomyosis associated infertility
 
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
 
Optimizing IUI Outcome
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
 
Preterm Labour
Preterm LabourPreterm Labour
Preterm Labour
 
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)    Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
 
recurrent pregnancy loss
recurrent pregnancy lossrecurrent pregnancy loss
recurrent pregnancy loss
 
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRole of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
 
Management of poor responders
Management of poor respondersManagement of poor responders
Management of poor responders
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1
 

Similar a recurrent pregnancy loss

Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy lossfaheta
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy lossAhmed Elbohoty
 
reccurent miscarriages.ppt
reccurent miscarriages.pptreccurent miscarriages.ppt
reccurent miscarriages.pptZunairaKhalid20
 
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)Ali Bendary
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015Lifecare Centre
 
Recurrent Loss 2009
Recurrent Loss 2009Recurrent Loss 2009
Recurrent Loss 2009Mark Perloe
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptxDrRokeyaBegum
 
Seminar Presentation Molina Dayal MD 9-13
Seminar Presentation Molina Dayal MD 9-13Seminar Presentation Molina Dayal MD 9-13
Seminar Presentation Molina Dayal MD 9-13SherInstitute
 
Bad obstetric history
Bad obstetric historyBad obstetric history
Bad obstetric historylimgengyan
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss DrRokeyaBegum
 
Threatened and unexplained repeated miscarriages
Threatened and  unexplained repeated miscarriagesThreatened and  unexplained repeated miscarriages
Threatened and unexplained repeated miscarriagesAboubakr Elnashar
 
Female infertility sp
Female infertility spFemale infertility sp
Female infertility spKriti Thapa
 
infertility evaluation in detail speroff
infertility evaluation in detail speroffinfertility evaluation in detail speroff
infertility evaluation in detail speroffDrMamathaPaleti1
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss drmcbansal
 
Recurrent Pregnancy Loss.ppt.pdf
Recurrent Pregnancy Loss.ppt.pdfRecurrent Pregnancy Loss.ppt.pdf
Recurrent Pregnancy Loss.ppt.pdflucensfuerte
 
RPL pptx.pptx
RPL pptx.pptxRPL pptx.pptx
RPL pptx.pptxalexmadhu
 
Recurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxRecurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxPuiteaChhangte
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labourlimgengyan
 

Similar a recurrent pregnancy loss (20)

Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
reccurent miscarriages.ppt
reccurent miscarriages.pptreccurent miscarriages.ppt
reccurent miscarriages.ppt
 
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)
Recurrent pregnancy loss: causes and diagnosis, myths and facts (evidence based)
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015
 
Recurrent Loss 2009
Recurrent Loss 2009Recurrent Loss 2009
Recurrent Loss 2009
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
 
Impact Of Genetic Testing For RPL Couples
Impact Of Genetic Testing For RPL CouplesImpact Of Genetic Testing For RPL Couples
Impact Of Genetic Testing For RPL Couples
 
Stillbirth
StillbirthStillbirth
Stillbirth
 
Seminar Presentation Molina Dayal MD 9-13
Seminar Presentation Molina Dayal MD 9-13Seminar Presentation Molina Dayal MD 9-13
Seminar Presentation Molina Dayal MD 9-13
 
Bad obstetric history
Bad obstetric historyBad obstetric history
Bad obstetric history
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss
 
Threatened and unexplained repeated miscarriages
Threatened and  unexplained repeated miscarriagesThreatened and  unexplained repeated miscarriages
Threatened and unexplained repeated miscarriages
 
Female infertility sp
Female infertility spFemale infertility sp
Female infertility sp
 
infertility evaluation in detail speroff
infertility evaluation in detail speroffinfertility evaluation in detail speroff
infertility evaluation in detail speroff
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
 
Recurrent Pregnancy Loss.ppt.pdf
Recurrent Pregnancy Loss.ppt.pdfRecurrent Pregnancy Loss.ppt.pdf
Recurrent Pregnancy Loss.ppt.pdf
 
RPL pptx.pptx
RPL pptx.pptxRPL pptx.pptx
RPL pptx.pptx
 
Recurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxRecurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptx
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labour
 

Último

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 

Último (20)

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 

recurrent pregnancy loss

  • 1. Recurrent pregnancy loss Kamel Mohamed Ibrahim M.B.B.CH – MSC ain shams University maternity hospital Specialist in fetomaternal medicine Member of Egyptian fertility society Member of Egyptian association of Gynelaparoscopists
  • 2. INTRODUCTION • The loss of pregnancy at any stage can be a devastating experience and particular sensitivity is required in assessing and counseling couples with recurrent miscarriage
  • 3. • A woman who has suffered a single sporadic miscarriage has an 80% chance and a woman with three consecutive miscarriages a 40-60% chance of her next pregnancy being successful
  • 5. This is our hope.
  • 6. Our Learning Objectives • Identify possible causes of early pregnancy loss. • Outline basic evaluation for recurrent pregnancy loss (RPL). • Review current treatment approaches for these patients.
  • 7. Definition • Miscarriage is defined as the spontaneous loss of pregnancy before the fetus reaches viability. • A recurrent miscarriage ₌ recurrent pregnancy loss (RPL) is 3 or more consecutive, spontaneous pregnancy losses (clinically recognized pregnancies) , under 20 week . Am J Obstet Gynecol 2005;192:240–6
  • 8. SUB TYPES : All pregnancy losses, no viable pregnancy Viable pregnancy followed by pregnancy losses Pregnancy losses interspersed with viable pregnancie RPL-TYPES : •Primary recurrent pregnancy loss" refers to couples that have never had a live birth, •“Secondary RPL" refers to those who have had repetitive losses following a successful pregnancy
  • 9. Easier to divide into 1st or 2nd trimester losses • 1st trimester losses : – – – – – PCOS (Polycystic ovary syndrome) APS (Antiphospholipid syndrome) Chromosomal abnormalities Endocrine disorders (untreated DM, thyroid disease) Uterine abnormalities • Submucous fibroid • Subseptate uterus • 2nd trimester losses : – – – – Cervical incompetence Asherman syndrome (intrauterine synechiae) Bacterial vaginosis Uterine abnormalities • Congenital – bicornuate, septate, subseptate, hypoplasia • Myomas – Thrombophilias
  • 10. Epidemiology • 50% of all conceptions fail (most unrecognized) • 13-15% of recognized pregnancies are lost, 90 % of these before 12-14 weeks • 10-20% of pregnant women have 1sporadic spontaneous abortion • 2% have 2 consecutive Spontaneous Abortion. • 0.4-1% have 3 consecutive Spontaneous Abortion. • Spontaneous successful pregnancy after 2miscarriage is 80% Lee Semin Reprod Med 2000;18(4):433-40
  • 11. Risk factors Advanced maternal age : 12-19 year:13% 20 -24 year: 11%Risk factors 25-30 year: 12% 31-35 year: 15% 36-40 year: 25% >40 year: 50% BMJ 2000;320:1708–12. Previous miscarriage : ↑ up to 40% after 3 consecutive pregnancy losses & prognosis worsens ѐ↑maternal age. Recurrent Pregnancy Loss 2007
  • 12. Environmental Risk Factors: The evidence on the effect of environmental risk factors is based mainly on data studying women with sporadic rather than recurrent miscarriage. Confirmed association Ionizing irradiation Organic solvents Alcohol Mercury Lead Suspected association  Caffeine (> 300 mg/day)  Cigarette smoking (However, current evidence is insufficient to confirm this association)  (Gardella & Hill Semin Reprod Med 2000;18(4):407-424) Acta Obstet Gynecol Scand 2003;82:182–8. Working with or using video display terminals does not increase the risk of miscarriage. (J Am Med Womens Assoc 2000;55:84–8, 105.) The evidence on the effect of anaesthetic gases for theatre workers is conflicting. (Mayo Clin Proc 2000;75:273–7). obesity increases the risk of both sporadic and recurrent miscarriage. (Fertil Steril 2010;94:290–5).
  • 13. AETIOLOGY Only in 50 %, the cause can be determined (Explained ) Lee Semin Reprod Med 2000;18(4):433-40 1. Genetic (embryonic and parental ) 2. Immunologic (autoimmune/alloimmune ) 3. Anatomical Factors (Uterine ) 4. Infectious causes . 5. Environmental 6. Endocrine 7. Hematologic disorders
  • 14. Genetic • Advanced Maternal age α errors in meiosis . • Oocytes ovulated earlier in life less prone to non dysjunction • Repetitive first trimester losses • Anembryonic pregnancies • History of malformations or mental retardation.
  • 15. Genetic • Embryonic chromosomal abnormalities : account for 30–57% of further miscarriages. (Hum Reprod 2002;17:446–51) – gametogenic error (^ with maternal age) . – Recurrent aneuploidy – Euploid abortion • Parental chromosomal abnormality 3-5% : The risk of miscarriage is influenced by the size and the genetic content of the rearranged chromosomal segments. – most commonly a balanced reciprocal or Robertsonian translocation. (BMJ 2006; 332:1012.) – Inversion – X chromosome mosaicsm
  • 16. Immune factors Autoimmune : (directed to self) Systemic Lupus Erythmatosus Antiphospholipid Syndrome Alloimmune :(directed to foreign tissues/cells) An abnormal maternal immune response to fetal or placental antigen.
  • 17. Systemic Lupus Erythmatosus (SLE) : -Risk for loss is 20%,mostly in 2nd and 3rd trimester of pregnancy and associated with antiphospholipid antibodies. Antiphospholipid syndrome (APA) : 5 - 15 % of women with RPL may have APA . inhibition of trophoblastic function and differentiation. Am J Obstet Gynecol 2005;192:23–30. activation of complement pathways at the maternal-fetal interface resulting in a local inflammatory response .( Lupus 2003;12:535–8.) in later pregnancy, thrombosis of the uteroplacental vasculature . (Am J Obstet Gynecol 1993;169:1403–6)
  • 18. Antiphospholipid syndrome An Autoimmune disorder having specific clinical & lab criteria: Clinical features: •Vascular thrombosis or •Loss of fetus at or after 10 weeks or •Preterm delivery at or before 34 weeks or •3 or more consecutive SAB before 10 weeks Laboratory features : •Anti-cardiolipin (aCL) antibodies: IgG or IgM at moderate or high levels on 2 or more occasions at least 12 weeks apart •Lupus anticoagulant (LA) antibodies: detected on 2 or more occasions at least 12 weeks apart
  • 19. Diagnosed by Revised Sapporo classification (2006): At least one clinical criteria and one laboratory criteria Clinical Laboratory Thrombosis ≥1 documented episodes of: Arterial Venous and/or Small vessel thrombosis ACA ACA of IgG and/or IgM isotype in medium/high titre (> 40 IU) or >99th percentile Pregnancy morbidity ≥1 unexplained fetal deaths of ≥ 10 weeks POA LA Detected (morphologically normal fetus) ≥1 premature births of ≤ 34th week POA d/t: Severe PE or Placental insufficiency (IUGR) Anti>99th percentile beta2glycopro tein (morphologically normal neonate) ≥3 unexplained consecutive spontaneous abortions < 10 week POA * On 2 or more occasions At least 12 weeks apart
  • 20. Alloimmune : Immune response to non-self components of pregnancy •Cytotoxic antibodies •Absence of maternal blocking antibodies •Inappropriate sharing of HLA •Disturbances in natural killer cell function and distribution. Porter Semin Reprod Med 2000;18(4):393-400 Natural killer cells: There is no clear evidence that altered peripheral blood NK cells are related to recurrent miscarriage. T helper (Th1) immunodystrophism Hum Reprod 2005;20:1123–6. A meta-analysisconcluded that the available data are not consistent with associations between cytokine polymorphisms and recurrent miscarriage. (Evidence level 2++)
  • 21. Anatomical Factors (Uterine ) Uterine anomalies : prevalence of uterine anomalies in recurrent miscarriage populations ranges between 1.8% and 37.6% Hum Reprod 2003;18:162–6. • Uterine septum (the anomaly most commonly associated with pregnancy loss) • Hemiuterus (unicornuate uterus) • Bicornuate uterus • Didelphic uteri Diethylstilbestrol-linked condition Acquired defects (eg, Asherman syndrome) Incompetent cervix Leiomyomas Uterine polyps Defective endometrial receptivity the role of uterine anomalies in recurrent miscarriage will remain debatable. untreated uterine anomalies let women experience high rates of miscarriage and preterm delivery, with a term delivery rate of only 50%. Hum Reprod Update 2001;7:161–74.
  • 23. SEPTATE UTERUS • a septate uterus Where as a partial septum increases the risk to 60%-75%; a total septum carries a risk for loss of up to 90%. • Most common. • poorest reproductive outcome. • Fetal survival with untreated cases 6 to 28 % • The mechanism – Not clearly understood – Poor blood supply »»» poor
  • 24. Bicornuate Uterus • 10% of anomalies • Incomplete fusion of Uterine horns at level of fundus • Two separate but communicating endometrial cavities • Abortion rate 30% • Preterm labour 20% • Metroplasty .
  • 25. Unicornuate Uterus • 20% of anomalies • Agenesis or hypoplasia of one Mullerian duct • May be alone or accompanied by Rudimentary horn With presence / absence of cavity Communicating / Non communicating • Associated Renal anomalies occur in 40% patients Ipsilateral to hypoplastic horn
  • 26. Uterus Didelphys • Least common anomaly -5-7% • associated with a miscarriage rate of 20.9% and a preterm delivery rate of 24.4% Hum Reprod 2003; 18:162–6.
  • 27. Cervical incompetence • Diagnosis is clinical, usually based on history – Miscarriage • • • • 2nd-trimester miscarriage Subsequent miscarriages are usually earlier Preceded by spontaneous rupture of membranes Bulging membranes through the cervix prior to onset of labour • Painless and progressive cervical dilatation • Fetus alive during miscarriage – History of cervical surgery (cone biopsy, LLETZ)
  • 28. LEIOMYOMA Unclear relationship between uterine leiomyomata and RPL • Submucous • The mechanism – Their position – Poor endometrial receptivity – Degeneration with increasing cytokine production
  • 29. OTHER UTERINE CAUSES • Endometrial polyps • Intrauterine adhesions – Curettage for pregnancy complications . – Traumatize basalis layer  granulation tissue – Insufficient endometrium to support fetoplacental growth – Menstrual irregularities (hypomenorrhea, amenorrhea), cyclic pelvic pain, infertility.
  • 30. Endocrine factors • • • • • Poorly controlled diabetes : – (↑Blood glucose & HbA1c levels in 1st trimester) ↑ risk for loss. – Miscarriage risk rises with the level of HbA1c – Well-controlled No ↑ risk thyroid disease . Anti-thyroid antibodies have been linked to recurrent miscarriage. Hyperprolactinemia Polycystic ovary syndrome (PCOS) Presence of at least 2 of the following 3 criteria: – Polycystic ovaries • • – – ≥ 12 follicles in each ovary (<10 mm (2-9 mm in diameter)) and/or Ovarian volume > 10 cm3 Oligomenorrhea and/or anovulation Clinical and/or biochemical hyperandrogenism
  • 31. • The increased risk of miscarriage in women with PCOS has been recently attributed to insulin resistance,hyperinsulinaemia and hyperandrogenaemia. (Hum Reprod 2000;15:612–5.) • An elevated free androgen index appears to be a prognostic factor for a subsequent miscarriage in women with recurrent miscarriage. (Hum Reprod 2008;23:797–802).
  • 32. Infective agents • No infectious agent has been proven to cause recurrent pregnancy loss • Certain infections have been associated with spontaneous loss – Toxoplasma Gondi, rubella, HSV, CMV, measles, coxsackie Lee Semin Reprod Med 2000;18(4):433-40 • Routine TORCH screening should be abandoned. RCOG, 2011.
  • 33. Bacterial vaginosis • Presence of BV in the first trimester – Reported as a risk factor for 2nd-trimester miscarriage or preterm delivery. Best Pract Res Clin Obstet Gynaecol 2007;21:375–90. • A RCT reported that treatment of BV early in the 2ndtrimester with oral clindamycin significantly reduces the incidence of second-trimester miscarriage and preterm birth in the general population. Lancet 2003;361:983–8. • No data to assess the role of antibiotic therapy in women with a previous second-trimester miscarriage.
  • 34. Hematologic disorders Women with heritable or acquired thrombophilic disorders have significantly increased risks of pregnancy loss . Kutteh Semin Reprod Med 2006;24(1):54-65 Inherited thrombophilic defects : • • • • Activated protein C resistance (most commonly due to factor V Leiden gene mutation). deficiencies of protein C/S and antithrombin III hyperhomocysteinaemia prothrombin gene mutation are established causes of systemic thrombosis
  • 35. Carriers of factor V Leiden or prothrombin gene mutation have double the risk of experiencing recurrent miscarriage compared with women without these thrombophilic mutations. Arch Intern Med 2004;164:558–63.
  • 36. MISCELLANEOUS • Environmental chemicals – Anesthetic gases • Sporadic spontaneous loss • No evidence of associations with RPL • Personal habits – Obesity »» ↑ Risk of Sporadic spontaneous loss and RPL – Smoking associated with ↑ Risk of spontaneous loss – Alcohol »» ↑ Risk of Sporadic spontaneous loss. – Caffeine associated with ↑ Risk of spontaneous loss • Exercise – does not ↑ sporadic or RPL
  • 37. Male factor : •Advanced paternal age may be a risk factor for miscarriage (at more advanced age than females) •Paternal HLA sharing not risk factor for RPL. •Aside from cytogenetic abnormalities, male factor contribution to RPL unknown Hill ASRM 2002 Course 6 p.56
  • 38. Idiopathic (Unexplained) • More than 50% of couples with RPL have no explanation despite extensive evaluation(s) • Informative and sympathetic counseling appears to play an important role Lee Semin Reprod Med 2000;18(4):433-40
  • 40. Detailed history : personal history : Age-<16y, >35 MH:oligomenorrhoea, PCO Present history: Pattern of losses and if a live embryo or fetus was present Exposure to environmental,toxins or drugs Known gynecological or obstetrical infections Features associated with APS OBH : GA<^6 w, 6-8w, FHR+/Past Surgical & Medical history: renal, look for autoimmune disease (SLE) , D&C , Previous diagnostic tests and treatments Family history : thrombophilia, birth defects, Consanguinity,RPL
  • 41. Examination : – General physical exam Wt, HT,BMI Features of PCOS Features of SLE Features of thyroid diseases – Pelvic exam Speculum –Any features of genital tract infection, anomalies, fibroids
  • 42. How and when to investigate?
  • 43. Ideally after 3 losses but American Society of reproductive medicine (ASRM 2008) Define as 2 consecutive miscarriage Earlier investigation/referral should be considered for special cases: Advanced maternal age (? How old) Bad obstetric history (e.g. ectopic, IUD) Medical disorders History of infertility, known family history. Patient request due to social reasons How to Investigate ? Investigate commoner and treatable causes first Do not order a blind screen
  • 44. • Antiphospholipid antibodies : ( Grade D) – Anticardiolipin antibodies (ACA) & Lupus anticoagulant 2 +ve tests (12 weeks apart ) • Karyotyping : (Grade D ) – Should be performed on products of conception (POC)of the 3rd and subsequent consecutive miscarriages – Parenteral karyotyping of both partners should be performed when testing of POC reports an unbalanced structural chormosomal abnormality. • Pelvic ultrasound – assess uterine anatomy : (√ ) – HSG can also be used as an initial screening test – Suspected uterine anomalies may require further investigations to confirm diagnosis: • Hysteroscopy • Laparoscopy • 3D ultrasound
  • 45. • 2D ultrasound scanning and/or HSG can be used as an initial screening test. Combined hysteroscopy and laparoscopy and possibly 3D ultrasound scanning should be used for definitive diagnosis. (3) Hum Reprod Update 2008;14:415–29. Thrombophilias : Women with second-trimester miscarriage should be screened for inherited thrombophilias including factor V Leiden, factor II (prothrombin) genemutation and protein S. ( 2++) Lancet 2003;361:901–8. away from the acute event when anticoagulation is discontinued when the woman is not pregnant or on the combined contraceptive pill.
  • 46. Endocrine factors • PCOS screen – Serum testosterone – SHBG • Screening for diabetes, thyroid disorders is only indicated if there is clinical suspicion. Not recommended as a routine test. Infective agents Not useful • TORCHES»»
  • 47. Recurrent Pregnancy Loss Causes, Controversies and Treatment 2007
  • 49. Management  Emotional aspect       Lost of pregnancy – can be a devastating traumatic experience Can lead to anxiety, stress & depression Instead of getting sympathy and support, often made to feel that it is somehow her fault Under intense pressure to provide a child for the family May even lead to family problem @ divorce Sensitivity is required in assessing and counselling couples   Approach with sympathy and understanding DO NOT blame, scold or make her feel at fault
  • 50. Treatment - APS • Pregnant women with APS should be treated with low-dose aspirin plus heparin to prevent further miscarriage. (B) (RCOG 2011) • Aspirin 81 mg po/day . • Subcutaneous unfractionated heparin 5000 - 10000 units/12 hours . • Alternative: LMWH(e.g., enoxaparin 1mg/kg/day) every 12 hours potential advantages: less heparin-induced thrombocytopenia . administered once daily . lower risk of heparin-induced osteoporosis. (RCOG 2011)
  • 51. Neither corticosteroids nor intravenous immunoglobulin therapy improve the live birth rate of women with recurrent miscarriage associated with APS. (A) (RCOG 2011)
  • 52. Management: Genetic Losses Abnormal parental karyotype should be referred to a geneticist. (D) Genetic counselling »» Reproductive options »»» a further natural pregnancy with or without a prenatal diagnosis test, gamete donation and adoption. Preimplantation Genetic Diagnosis (PGD) : proposed as a treatment option for translocation carriers Hum Fertil (Camb) 2001;4:168–71.
  • 53. Uterine Abnormalities Treatment Uterine septum: Hysteroscopy septal resection and temporary intrauterine device. Intrauterine adhesions : hysteroscopic division and temporary intrauterine device: postoperative course of cyclic estrogen and progesterone therapy. Fibroids: myomectomy In women with a singleton pregnancy and a history of one second-trimester miscarriage attributable to cervical factors, an ultrasound-indicated cerclage should be offered if a cervical length of 25mm or less is detected by transvaginal scan before 24 weeks . (B) RCOG 2011
  • 54. Management : Endocrine factors There is insufficient evidence to evaluate the effect of progesterone supplementation in pregnancy to prevent a miscarriage (RCOG 2011) However newer evidences is coming up as large multicentre study PROMISE is currently on the way. (PROMISE,http://www.medscinet.net/promise)
  • 55. There is insufficient evidence to evaluate the effect of human chorionic gonadotrophin supplementation in pregnancy to prevent a miscarriage in women with recurrent miscarriage. (B) Suppression of high luteinising hormone levels among ovulatory women with recurrent miscarriage and polycystic ovaries does not improve the live birth rate. (A) (RCOG 2011)
  • 56. PCOS • Role of Metformin – Previously prescribed to reduce risk of recurrent miscarriage – Insufficient evidence to evaluate the effect of metformin supplementation – Recent meta-analysis of 17 RCTs - metformin has no effect on sporadic miscarriage risk – Uncontrolled small studies (no RCTs) – associated with reduction in miscarriage rate in women with recurrent miscarriage
  • 57. Immunotherapy Paternal cell immunisation third-party donor leucocytes trophoblast membranes and intravenous immunoglobulin (IVIG) »»»»previous unexplained recurrent miscarriage does not improve the live birth rate . (A)
  • 58. Treatment Inherited thrombophilias For heritable or acquired thrombophilia: heparin anticoagulation For elevated homocysteinemia without thrombosis history (Supplementation with Vitamin B6, B12 and folic acid) (Heparin anticoagulation for history of thrombosis) Heparin therapy during pregnancy may improve the live birth rate of women with second-trimester miscarriage associated with inherited thrombophilias. (A)
  • 59. Management – Unexplained RM • Women with unexplained recurrent miscarriage have an excellent prognosis for future pregnancy outcome without pharmacological intervention if offered supportive care alone in the setting of a dedicated early pregnancy assessment unit. (B) • 75% chance of a eventual live birth in subsequent pregnancy However, prognosis worsens with: • Increasing maternal age • Number of previous miscarriages the use of empirical treatment in unexplained recurrent miscarriage is unnecessary and should be resisted RCOG 2011
  • 60. Unexplained recurrent miscarriage Preimplantation genetic screening with in vitro fertilisation treatment in women with unexplained recurrent miscarriage does not improve live birth rates. (C) Two recent randomised controlled trials reported that neither of (Aspirin alone or in combination with heparin) improves the live birth rate among women with unexplained recurrent miscarriage. (N Engl J Med 2010;362:1586–96.) (Blood 2010;115:4162–7.)
  • 61. immunological • Paternal cell immunisation, third-party donor leucocytes, trophoblast membranes • and intravenous immunoglobulin in women with previous unexplained recurrent • miscarriage does not improve the live birth rate Thank You